Ontology highlight
ABSTRACT: Background
Uveal melanoma is an aggressive cancer with high metastatic risk. Recently, we identified a circulating cancer cell population that co-expresses neoplastic and leukocyte antigens, termed circulating hybrid cells (CHCs). In other cancers, CHCs are more numerous and better predict oncologic outcomes compared to circulating tumor cells (CTCs). We sought to investigate the potential of CHCs as a prognostic biomarker in uveal melanoma.Methods
We isolated peripheral blood monocular cells from uveal melanoma patients at the time of primary treatment and used antibodies against leukocyte and melanoma markers to identify and enumerate CHCs and CTCs by immunocytochemistry.Results
Using a multi-marker approach to capture the heterogeneous disseminated tumor cell pop
SUBMITTER: Parappilly MS
PROVIDER: S-EPMC9564048 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature